Pharmacoeconomic plan on two therapeutic category hit snag

Published: 2007-11-29 06:59:00

Updated: 2007-11-29 06:59:00

The government will be unlikely to announce its results of 295 medicines falling into two therapeutic categories (anti-hyperlipidemic and anti-migraine agents) in December, according to the Health Insurance Review Agency (HIRA)

In a workshop on November 26, a HiRA official said that the gover...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK